Fig. 1From: Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIVFlow chart of participants who consulted after sexual exposure to HIV and were prescribed EVG/c/FTC/TAF in 2020 or DOR/3TC/TDF in 2021Back to article page